NASDAQ:OFIX - Orthofix Medical Stock Price, Forecast & News

Orthofix Medical trades on the NASDAQ under the ticker symbol "OFIX."

Orthofix Medical Inc (NASDAQ:OFIX) announced its quarterly earnings results on Monday, February, 24th. The medical device company reported $0.51 earnings per share for the quarter, meeting the consensus estimate of $0.51. The medical device company had revenue of $121.49 million for the quarter, compared to analysts' expectations of $122.90 million. Orthofix Medical had a negative net margin of 6.19% and a positive return on equity of 8.58%. View Orthofix Medical's Earnings History.

Orthofix Medical is scheduled to release their next quarterly earnings announcement on Monday, May 4th 2020. View Earnings Estimates for Orthofix Medical.

Orthofix Medical issued an update on its first quarter 2020 After-Hours earnings guidance on Monday, February, 24th. The company provided earnings per share guidance of 0.09-0.12 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.32. The company issued revenue guidance of $106-109 million, compared to the consensus revenue estimate of $113.27 million.

2 equities research analysts have issued 12-month price targets for Orthofix Medical's stock. Their forecasts range from $42.00 to $56.00. On average, they expect Orthofix Medical's stock price to reach $49.00 in the next twelve months. This suggests a possible upside of 38.7% from the stock's current price. View Analyst Price Targets for Orthofix Medical.

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Orthofix Medical in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Orthofix Medical.

News coverage about OFIX stock has trended somewhat positive on Friday, InfoTrie reports. The research firm ranks the sentiment of media coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Orthofix Medical earned a news impact score of 1.1 on InfoTrie's scale. They also assigned news articles about the medical device company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the company's share price in the near term. View News Stories for Orthofix Medical.

Orthofix Medical saw a decline in short interest in February. As of February 14th, there was short interest totalling 284,300 shares, a decline of 10.1% from the January 30th total of 316,400 shares. Based on an average trading volume of 114,300 shares, the short-interest ratio is currently 2.5 days. Approximately 1.6% of the company's stock are short sold. View Orthofix Medical's Current Options Chain.

Some companies that are related to Orthofix Medical include Abbott Laboratories (ABT), Medtronic (MDT), Stryker (SYK), Becton Dickinson and (BDX), Intuitive Surgical (ISRG), Boston Scientific (BSX), Edwards Lifesciences (EW), Baxter International (BAX), DexCom (DXCM), ResMed (RMD), IDEXX Laboratories (IDXX), Teleflex (TFX), Steris (STE), Hologic (HOLX) and Varian Medical Systems (VAR).

Based on aggregate information from My MarketBeat watchlists, some companies that other Orthofix Medical investors own include AbbVie (ABBV), Enterprise Products Partners (EPD), Exxon Mobil (XOM), Clovis Oncology (CLVS), Esperion Therapeutics (ESPR), Gilead Sciences (GILD), iCAD (ICAD), Intercept Pharmaceuticals (ICPT), Madrigal Pharmaceuticals (MDGL) and Zogenix (ZGNX).

Orthofix Medical's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Paradice Investment Management LLC (4.36%), State Street Corp (3.59%), Goldman Sachs Group Inc. (2.64%), Dalton Greiner Hartman Maher & Co. (2.23%), Renaissance Technologies LLC (1.94%) and Geode Capital Management LLC (1.65%). Company insiders that own Orthofix Medical stock include Brad Mason, Bradley V Niemann, Davide Bianchi, Kimberley A Elting, Luke T Faulstick, Rice Doug and Ronald A Matricaria. View Institutional Ownership Trends for Orthofix Medical.

OFIX stock was sold by a variety of institutional investors in the last quarter, including Victory Capital Management Inc., Victory Capital Management Inc., Marshall Wace LLP, Mackay Shields LLC, AJO LP, Renaissance Technologies LLC, SG Americas Securities LLC and Geode Capital Management LLC. View Insider Buying and Selling for Orthofix Medical.

OFIX stock was purchased by a variety of institutional investors in the last quarter, including Royce & Associates LP, Dalton Greiner Hartman Maher & Co., Bank of Montreal Can, Jacobs Levy Equity Management Inc., Great West Life Assurance Co. Can, Thrivent Financial for Lutherans, Paradice Investment Management LLC and Charles Schwab Investment Management Inc.. View Insider Buying and Selling for Orthofix Medical.

Shares of OFIX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of OFIX stock can currently be purchased for approximately $35.34.

Orthofix Medical has a market capitalization of $673.40 million and generates $459.95 million in revenue each year. The medical device company earns $13.81 million in net income (profit) each year or $1.47 on an earnings per share basis. Orthofix Medical employs 954 workers across the globe.View Additional Information About Orthofix Medical.

The official website for Orthofix Medical is http://www.orthofix.com/.

Orthofix Medical's mailing address is 3451 Plano Parkway, Lewisville TX, 75056. The medical device company can be reached via phone at 214-937-2000 or via email at [email protected]